In healthy men with a low risk of HIV-1 infection, cabotegravir, an HIV-1 integrase strand transfer inhibitor with antiviral activity, was safe and well tolerated despite having a high number of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results